We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore the cost of Repatha in India, factors influencing its price, insurance coverage, and available financial assistance programs to manage high cholesterol.

Repatha, a revolutionary medication designed to manage high cholesterol levels, has brought hope to many individuals struggling with cardiovascular health. However, like many advanced medical treatments, understanding its cost and exploring available assistance options is crucial, especially for patients in India. This comprehensive guide aims to demystify the price of Repatha, discuss factors influencing its cost, and highlight various avenues for financial and insurance support.
Repatha (evolocumab) is a prescription medication belonging to a class of drugs called PCSK9 inhibitors. It works by helping to lower levels of low-density lipoprotein (LDL) cholesterol, often referred to as 'bad' cholesterol, in the blood. High LDL cholesterol is a significant risk factor for heart disease, and Repatha offers a powerful new way to manage this condition, particularly for individuals who haven't achieved their goals with statins or other cholesterol-lowering therapies.
The medication is typically administered via subcutaneous injection, either using a prefilled syringe or an autoinjector device. Its mechanism of action involves targeting and inhibiting the PCSK9 protein, which in turn increases the number of LDL receptors on the liver. These receptors are responsible for removing LDL cholesterol from the bloodstream, thus leading to a significant reduction in LDL levels.
The price of Repatha in India can vary based on several key factors:
For individuals with health insurance in India, understanding how Repatha is covered is essential. Many insurance providers may require a prior authorization before covering the cost of such advanced medications. This process involves your doctor submitting a request to the insurance company, detailing your medical condition, treatment history, and why Repatha is medically necessary for your care.
What is Prior Authorization?
Prior authorization is a process where your insurance company reviews and approves a prescribed medication or treatment before you receive it. This is to ensure that the medication is appropriate for your condition and that it aligns with the terms of your insurance policy.
Steps to Navigate Insurance:
Recognizing the potential cost barrier, the manufacturer of Repatha, Amgen, often provides financial assistance programs to eligible patients. These programs are designed to make the medication more accessible.
Amgen may offer a Repatha Copay Card or a similar financial assistance program. This program can help reduce the out-of-pocket costs for eligible patients with commercial insurance. To learn more about eligibility criteria and how to apply, you should:
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026

Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026